Skip to content

Parabilis Medicines, Inc.

PBLS· NasdaqCore metricsCIK 1657677

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -6.49%
Market cap
$3.38B
122.08M shares
Filings
65
$2.11M
Q3 2026
—
-$44.49M
Q3 2026
—
-$54.74M
Q3 2026
—
-$95.50M
Q3 2026derived
—
-$0.36
Q3 2026
—
$521.20M
Q3 2026−44.7% FY25 yoy
$3.38B
—
—
3.4×
—
—

FY2026 figures · derived

Price

$27.7212.29%$3.89since Jun 10, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.11MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Parabilis Medicines, Inc. is the 71st largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Parabilis Medicines, Inc. · CIK 1657677 · Engraved from SEC EDGAR